Cyclomics: Funding, Investors & Team (Oct 2026)
Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology. Accurate measurement of cancer recurrence and monitoring of treatment responses are important clinical needs in cancer diagnostics. The limitations of existing (imaging-based) methods poses a significant impediment to effective (re-)treatment and overall survival. The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results, and delivering superior performance to standard radiological and/or physical examination alone. CyclomicsSeq's first application will be for head and neck cancers (HNC), where monitoring of treatment response and recurrence disease is essential for improving survival.
Cyclomics has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Jan 2026.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Cyclomics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Cyclomics Funding Rounds
Cyclomics Founders and Leadership Team
No contact details are on record for this team yet.
Cyclomics Funding Compared to Other Health Care Startups
Cyclomics' latest round of $3.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cyclomics in Health Care and Utrecht
Companies Similar to Cyclomics
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and…
CureMeAbroad operates as an AI-powered medical tourism concierge, matching patients from Western markets.
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Cyclomics Funding FAQs
What does Cyclomics do?
Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology. Accurate measurement of cancer recurrence and monitoring of treatment responses are important clinical needs in cancer diagnostics. The limitations of existing (imaging-based) methods poses a significant impediment to effective (re-)treatment and overall survival. The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results, and delivering superior performance to standard radiological and/or physical examination alone. CyclomicsSeq's first application will be for head and neck cancers (HNC), where monitoring of treatment response and recurrence disease is essential for improving survival.
How much funding has Cyclomics raised?
Cyclomics has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Jan 2026.
When did Cyclomics last raise funding?
Cyclomics' most recent funding round on record is an undisclosed round of $3.0M, announced in Jan 2026.
Who founded Cyclomics?
FundedIQ lists Jeroen De Ridder (Founder) at Cyclomics.
Where is Cyclomics headquartered?
Cyclomics is based in Utrecht, Utrecht, The Netherlands.
How many employees does Cyclomics have?
Cyclomics is in the 1-10 employee band.
How does Cyclomics' funding compare to other Health Care startups?
Cyclomics' latest round of $3.0M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Cyclomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cyclomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.